candesartan cilexetil and fibrinogen

candesartan cilexetil has been researched along with fibrinogen in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujimura, A; Sugimoto, K; Tsuruoka, S1
Monteduro, C; Muiesan, ML; Porteri, E; Rizzoni, D; Rosei, EA; Salvetti, M; Sleiman, I1

Trials

1 trial(s) available for candesartan cilexetil and fibrinogen

ArticleYear
Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus.
    Journal of hypertension, 2005, Volume: 23, Issue:2

    Topics: Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Enalapril; Female; Fibrinogen; Humans; Hypertension; Intercellular Adhesion Molecule-1; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Tetrazoles; Vascular Cell Adhesion Molecule-1; von Willebrand Factor

2005

Other Studies

1 other study(ies) available for candesartan cilexetil and fibrinogen

ArticleYear
Effect of prolonged nitric oxide synthesis inhibition on plasma fibrinogen concentration in rats.
    Japanese journal of pharmacology, 2001, Volume: 85, Issue:1

    Topics: Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Enzyme Inhibitors; Fibrinogen; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Tetrazoles

2001